StockData

Drugs Made In America Acquisition Corp. (DMAA) stock

DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)

Close on Nov 16, 2026Market cap $264.62MP/E –Yield –

Drugs Made In America Acquisition total assets

Total assets on the balance sheet at the end of each period.

Drugs Made In America Acquisition's total assets was $146.90M at Jun 30, 2026. For fiscal 2025 it was $239.92M, up 43456.4% from the year before.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$239.92M+43456.4%
FY2024Dec 31, 2024$550.82K–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$146.90M-37.5%
Q1 FY2026Mar 31, 2026$242.04M+4.0%
Q4 FY2025Dec 31, 2025$239.92M+43456.4%
Q3 FY2025Sep 30, 2025$237.63M–
Q2 FY2025Jun 30, 2025$235.21M–
Q1 FY2025Mar 31, 2025$232.81M–
Q4 FY2024Dec 31, 2024$550.82K–

More Drugs Made In America Acquisition figures

See a number that looks wrong?